TrialPloS one2015

Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity.

Lena Winstedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.